Akio Yamasaki

Kyushu University — Japan

Biochemistry, Genetics and Molecular Biology · Life Sciences

16h-index1.3kcitations53works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Hedgehog Signaling Pathway Studies(10), Epigenetics and DNA Methylation(9), Cancer, Hypoxia, and Metabolism(9), Immunotherapy and Immune Responses(7), Cancer-related Molecular Pathways(7)

Publications53 total

P60-1 Safety and feasibility of hyper short-hydration using furosemide in cisplatin-based chemotherapy
Annals of Oncology·2022
PTPN3 Could Βe a Therapeutic Target of Pancreatic Cancer
Anticancer Research·2022
Cancer therapy that targets the Hedgehog signaling pathway considering the cancer microenvironment (Review)
Oncology Reports·2022· 13 citedOpen Access
TrkB/BDNF Signaling Could Be a New Therapeutic Target for Pancreatic Cancer
Anticancer Research·2021· 14 citedOpen Access
Hypoxia and pancreatic ductal adenocarcinoma
Cancer Letters·2020· 87 cited
Protein tyrosine phosphatase non-receptor type 3 (PTPN3) could be a new therapeutic target for pancreatic cancer
Annals of Oncology·2019Open Access
P2.14-44 Tumor Mutation Burden and Efficacy of Molecular Targeted Therapy in Lung Cancer
Journal of Thoracic Oncology·2019· 1 cited
Liprin-α4 as a New Therapeutic Target for SCLC as an Upstream Mediator of HIF1α
Anticancer Research·2019· 11 citedOpen Access
Liprin-alpha4 contributes to increased proliferation and decreased chemosensitivity under hypoxia for small cell lung cancer as a downstream mediator of HIF-1alphaα
Annals of Oncology·2018· 2 citedOpen Access
RBPJ and MAML3: Potential Therapeutic Targets for Small Cell Lung Cancer
Anticancer Research·2018· 20 citedOpen Access
The Novel Selective Pan-TRK Inhibitor ONO-7579 Exhibits Antitumor Efficacy Against Human Gallbladder Cancer In Vitro
Anticancer Research·2018· 5 citedOpen Access
Liprin-α4 as a Possible New Therapeutic Target for Pancreatic Cancer
Anticancer Research·2017· 14 citedOpen Access
P2.03-016 Clinical Utility of Liquid Biopsy for Detecting EGFR T790M Mutation Is Very Limited
Journal of Thoracic Oncology·2017Open Access
C4orf47 contributes to the induction of malignant phenotypes in pancreatic cancer
Annals of Oncology·2017
P1.01-064 Efficacy and Tolerability of Nivolumab in Elderly Patients with Advanced Non-Small Cell Lung Cancer
Journal of Thoracic Oncology·2017
Hedgehog Inhibition Upregulates TRK Expression to Antagonize Tumor Suppression in Small Cell Lung Cancer Cells
Anticancer Research·2017· 8 citedOpen Access
Phase 1 study of ipatasertib (AKT inhibitor) for investigating safety, tolerability, pharmacokinetics (PK), efficacy, and biomarkers in Japanese patients (pts) with solid tumors including castration-resistant prostate cancer (CRPC)
Annals of Oncology·2017
Liprin-α4 could be a potential therapeutic target for pancreatic cancer
Annals of Oncology·2017· 9 citedOpen Access
Abstract 589: Hedgehog signaling augments PDL-1 expression in cancer cells under hypoxic condition to inhibit antitumor effects by activated lymphocytes
Cancer Research·2017· 2 cited
Abstract 5794: TrkB-mediated signaling contributes to malignant phenotypes of gallbladder cancer
Cancer Research·2017
page 1 of 3Next →

Frequent Co-authors

Hideya Onishi(36), Takashi Morisaki(18), Mitsuo Katano(16), Makoto Kawamoto(16), Shuntaro Nagai(12), Akira Imaizumi(12), Junji Wada(9), Masafumi Nakamura(9), Kosuke Yanai(9), Yasuhiro Oyama(9), Akiko Fujimura(8), Masao Tanaka(6), Haruo Tanaka(6), Katsuya Nakamura(6), Keigo Ozono(6), Hiroyuki Suzuki(5), Chizu Kameda(5), Masayo Umebayashi(5), Kenichiro Koga(4), Makoto Kubo(4)